Exclusive-Investor Artisan Partners backs Unilever’s plan to sell food unit

Unilever will merge its food business with McCormick to create a company worth about $65 billion. Unilever shares fell ~7% (wiping roughly $7 billion of market value) and McCormick shares slid about 5% after the announcement. Artisan Partners (1.22% stake, ~$1.6 billion) called the deal tax-efficient and said it enables Unilever to focus on higher-growth personal care and beauty units, while some investors are concerned about the transaction structure, long closing timeline and potential antitrust scrutiny.

Analysis

The structural takeaway is valuation arbitrage: separating a slower-growth, margin-rich food franchise from faster-growth personal care creates two distinct multiple profiles. Expect the personal care/home cohort to trade at a 200-400bps higher EV/EBITDA or 3-6x higher P/E multiple than the combined group within 12-24 months if execution is clean, while the carved-out food business will attract strategic buyers or consolidators seeking stable cash yields, pressuring its multiple lower.

Regulatory and execution frictions are the primary near-term dampeners. Antitrust clearance and remedy negotiation typically take 6-18 months for transactions of this scale and can force asset sales that dilute projected synergies by ~10-30% and increase integration costs, creating a binary path to upside or prolonged value erosion.

Second-order winners include premium personal-care peers and asset managers that can arbitrage the gap — active funds or private equity likely to step into the food carve-out if valuation proves accretive; losers include mid-tier ingredient and co-packing vendors who will face margin pressure as a larger consolidated buyer rationalizes SKUs and pushes for procurement savings.

Catalysts and timing: activist-driven governance changes and the formal separation timeline are 3-24 month catalysts; quarterly guidance revisions and early integration headlines will move sentiment within days-weeks. The tradeable window with highest asymmetry is the period between announcement and regulatory sign-off when sentiment and positioning diverge but price has already discounted some long-term upside.

Key Decisions for Investors

• Pair trade (12-24 months): Long EL (Estée Lauder) + short UL (Unilever) sized 1:1 — rationale: capture re-rating of pure-play beauty vs the drag/uncertainty of a protracted carve-out. Position size: modest (2-4% net exposure); stop-loss: 20% adverse move in spread; target: 25-40% realized spread tightening.
• Event hedge (0-9 months): Buy UL 6-9 month protective puts (delta ~0.30) while accumulating a small core long UL position — protects against antitrust/execution downside while retaining upside to eventual rerate. Risk/reward: cost of puts ~2-4% of position; payoff asymmetric if regulatory headlines turn negative.
• Short MKC (McCormick) or buy 12-month puts sized to 1-2% portfolio — thesis: integration risk and potential overpayment compress returns; catalysts: margin revision, share-based consideration dilution. Risk: deal completes accretively; limit loss to 25% of notional short.
• Opportunistic long (18-36 months): Accumulate personal-care pure-plays and premium brands (EL, discretionary allocations to L'Oréal where accessible) on post-deal clarity — expect 20-35% upside if separation achieves higher multiple. Use trailing stops and reduce into strength as multiples expand.